Antiamoebic drugs for treating amoebic colitis

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 1, 2019, Pages

  Gonzales, Maria Liza M ^a   Dans, Leonila F ^a   Sio Aguilar, Juliet ^a  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIAMEBIC AGENT; METRONIDAZOLE; PLACEBO; TINIDAZOLE;

ADVERSE EVENT; AMEBIASIS; AMOEBIC CULTURE; COMBINATION DRUG THERAPY; ENTAMOEBA HISTOLYTICA; EVIDENCE BASED MEDICINE; FECES ANALYSIS; HUMAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REVIEW; RISK ASSESSMENT; SIDE EFFECT; STOOL ANTIGEN TEST; SYSTEMATIC REVIEW; UNCERTAINTY; ANIMAL; DYSENTERY; META ANALYSIS; PARASITOLOGY;

AMEBICIDES; ANIMALS; DRUG THERAPY, COMBINATION; DYSENTERY, AMEBIC; ENTAMOEBA HISTOLYTICA; HUMANS; METRONIDAZOLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TINIDAZOLE;

EID: 85059762614     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006085.pub3     Document Type: Review

References (314)

1. Asrani CH, Damle SS, Ghotge VV, Gokhale AS, Jalgaonkar M, Pai Kakode PR, et al. Efficacy and safety of metronidazole versus a combination of metronidazole and diiodohydroxyquinoline for the treatment of patients with intestinal amebiasis: a Primary Care Physician Research Group Study. Current Therapeutic Research 1995;56(7):678-83. 2919530
2. Awal ARMA, Ali S. Tinidazole in the treatment of symptomatic intestinal amoebiasis. Current Therapeutic Research 1979;26(6):962-6. 2919532
3. Batra SK, Ajmani NK, Chuttani HK. Evaluation of 1-methyl-2-(4'-fluorophenyl)-5-nitroimidazole. Journal of Tropical Medicine and Hygiene 1972;75(2):40-1. 2919534
4. Botero D. Double blind study with a new nitroimidazole derivative, Ro 7-0207, versus metronidazole in symptomatic intestinal amebiasis. American Journal of Tropical Medicine and Hygiene 1974;23(5):1000-1. 2919536
5. Botero D, Perez A. Treatment of intestinal amoebiasis and vaginal trichomoniasis with panidazole and its comparison with metronidazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 1977;71(6):508-11. 2919538
6. Chunge CN, Estambale BB, Pamba HO, Chitayi PM, Munanga PN, Kang'ethe S. Comparison of four nitroimidazole compounds for treatment of symptomatic amoebiasis in Kenya. East African Medical Journal 1989;66(11):724-7. 2919540
7. Davila-Gutierrez C, Vasquez C, Trujillo-Hernandez B, Huerta M. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. American Journal of Tropical Medicine and Hygiene 2002;66(3):251-4. 2919542
8. Donckaster R, Atias A, Faiguenbaum J, Jarpa A, Sapunar J, Cuello E. Chronic intestinal amebiasis. Therapeutic trial of antibiotics, chemotherapeutics and placebos [Amibiasis intestinal cronica. Ensayo terapeutico con antibioticos, quimioterapicos y placebo]. Boletin Chileno de Parasitologia 1964;19:46-54. 2919544
9. Guevara L. Evaluation of the tolerance and efficiency of quinfamide, a new intraluminal amebicide, in man (one day treatment). Double blind study. Revista de Gastroenterologia de Mexico 1980;45(2):93-7. 2919546
10. Huggins D. Double-blind clinical trial with WIN 40.014 in the treatment of intestinal chronic amebiasis [Ensaio clinico duplo-cego com o WIN 40.014 no tratamento da amebiase intestinal cronica]. Folha Medica 1982;85 Suppl 1:869-70. 2919548
11. Joshi HD, Shah BM. A comparative study of tinidazole and metronidazole in treatment of amoebiasis. The Indian Practitioner 1975;28:295-302. 2919550
12. Kapadia RM, Pathak HY, Apte SP. Chlorhydroxyquinoline and di-iodohydroxyquinoline in amoebiasis: a comparative study. Journal of the Indian Medical Association 1968;51(3):125-7. 2919552
13. Karabay O, Godekmerden A. Comparison of therapeutic efficacies of the single dose secnidazole versus 10-day metronidazole in acute amebiasis [Akut intestinal amebiyaz tedavisinde tek doz seknidazol ile 10 gunluk metronidazolun etkinliklerinin karsilastirilmasi]. Klimik Dergisi 1999;12(2):82-4. 2919554
14. Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World Journal of Gastroenterology 2003;9(8):1832-3. 2919556
15. Mathur SN, Itigi A, Rao PD, Krishnaveni, Rai V. Evaluation of tinidazole in treatment of amoebiasis. Indian Medical Gazette 1976;15:361-4. 2919558
16. Misra NP, Laiq SM. Comparative trial of tinidazole and metronidazole in intestinal amebiasis. Current Therapeutic Research 1974;16(12):1255-63. 2919560
17. Misra NP, Gupta RC. A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis. Journal of International Medical Research 1977;5(6):434-7. 2919562
18. Misra NP. A comparative study of tinidazole and metronidazole as a single daily dose for three days in symptomatic intestinal amoebiasis. Drugs 1978;15 Suppl 1:19-22. 2919564
19. Mohammed KA, Strak SK, Jawad AM, Al-Sadoon IO, Mahdi NK. Effectiveness of praziquantel in treatment of intestinal amoebiasis and giardiasis. Eastern Mediterranean Health Journal 1998;4(1):161-3. 2919566
20. Naoemar SA, Rukmono B. Clinical trial of Ro 7-0207, a nitroimidazole derivative, in amoebic dysentery. Southeast Asian Journal of Tropical Medicine and Public Health 1973;4(3):417-20. 2919568
21. Nnochiri E. Oral chemotherapy in amoebic dysentery - potentiating effect of chloroquine on the action of diloxanide furoate. Journal of Tropical Medicine and Hygiene 1967;70(9):224-8. 2919570
22. Padilla N, Diaz R, Munoz M. Efficacy and safety of quinfamide versus secnidazole in the management of amoebic non-dysenteric colitis in children. Clinical Drug Investigation 2000;20(2):89-93. 2919572
23. Pamba HO, Estambale BB, Chunge CN, Donno L. Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya. European Journal of Clinical Pharmacology 1990;39(4):353-7. 2919574
24. Panggabean A, Sutjipto A, Aldy D, Sutanto AH, Siregar H. Tinidazole versus ornidazole in amebic dysentery in children (a double blind trial). Paediatrica Indonesiana 1980;20(11-12):229-35. 2919576
25. Pehrson P, Bengtsson E. Treatment of non-invasive amoebiasis. A comparison between tinidazole alone and in combination with diloxanide furoate. Transactions of the Royal Society of Tropical Medicine and Hygiene 1983;77(6):845-6. 2919578
26. Pehrson P, Bengtsson E. Treatment of non-invasive amoebiasis - a comparison between tinidazole and metronidazole. Annals of Tropical Medicine and Parasitology 1984;78(5):505-8. 2919580
27. Prasad R, Jagota SC, Mathur PP, Taneja V. Drug trial of 'Dependal' - M suspension against metronidazole suspension in amoebiasis and giardiasis. Indian Medical Gazette 1985;119(7):219-23. 2919582
28. Pudjiadi SH, Sunoto, Suharjono, Kadri N. A new oral amoebicid (RO 7-0207) in the treatment of intestinal amoebiasis. Paediatrica Indonesiana 1973;13(4):113-9. 2919584
29. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. Journal of Infectious Diseases 2001;184(3):381-4. 2919586
30. Rossignol JF, Kabil SM, El Gohary Y, Younis AM. Nitazoxanide in the treatment of amoebiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007;101(10):1025-31. 2919588
31. Rubidge CJ, Scragg JN, Powell SJ. Treatment of children with acute amoebic dysentery. Comparative trial of metronidazole against a combination of dehydroemetine, tetracycline, and diloxanide furoate. Archives of Disease in Childhood 1970;45(240):196-7. 2919590
32. Salles JMC, Bechara C, Tavares AM, Martins M, Sobrinho JG, Dietrich-Neto F, et al. Comparative study of the efficacy and tolerability of secnidazole suspension (single dose) and tinidazole suspension (two days dosage) in the treatment of amebiasis in children. Brazilian Journal of Infectious Diseases 1999;3(2):80-8. 2919592
33. Savas-Erdeve S, Gokay S, Dallar Y. Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children. Turkish Journal of Pediatrics 2009;51(3):220-4. 2919594
34. Shah SMA, Usmanghani K, Akhtar N, Akram M, Asif HM, Hasan MM. Clinical study on the efficacy of Amoebex (coded herbal drug) compared with metronidazole for the treatment of amoebic dysentery. Pakistan Journal of Pharmaceutical Sciences 2016;29(6):2005-14. 9828084
35. Siddiqui MI, Usmanghani K. Comparison of how well allopathic and herbal medicine work for the treatment of Entamoeba histolytica. Journal of Medicinal Plants Research 2015;9(9):301-9. 2919596
36. Singh G, Kumar S. Short course of single daily dosage treatment with tinidazole and metronidazole in intestinal amoebiasis: a comparative study. Current Medical Research and Opinion 1977;5(2):157-60. 2919598
37. Sitepu N, Lubis CP, Sutanto AH, Siregar H. Minute treatment with tinidazole and ornidazole in children with amebic dysentery. Paediatrica Indonesiana 1982;22(7-8):132-5. 2919600
38. Soedin K, Alfien Syukran OK, Fadillah A, Sidabutar P. Comparison between the efficacy of a single dose of secnidazole with a 5-day course of tetracycline and clioquinol in the treatment of acute intestinal amoebiasis. Pharmatherapeutica 1985;4(4):251-4. 2919602
39. Swami B, Lavakusulu D, Devi CS. Tinidazole and metronidazole in the treatment of intestinal amoebiasis. Current Medical Research and Opinion 1977;5(2):152-6. 2919604
40. Toppare MF, Kitapci F, Senses DA, Yalcinkaya F, Safa Kaya I, Dilmen U. Ornidazole and secnidazole in the treatment of symptomatic intestinal amoebiasis in childhood. Tropical Doctor 1994;24(4):183-4. 2919606
41. Tripathi BM, Misra NP, Tiwari A. A double-blind trial of GO 10213 and metronidazole in intestinal amoebiasis. Current Therapeutic Research 1986;39(2):178-82. 2919608
42. Abdallah A, Gad-el-Mawla N, el-Kordy MI. Erythromycin stearate in intestinal amoebiasis. Journal of the Egyptian Medical Association 1969;52(2):168-73. 2919610
43. Abd-Rabbo H, Montasir M. A trial of oral dehydroemetine compounds in the treatment of amoebiasis. Journal of Tropical Medicine and Hygiene 1969;72(3):64-7. 2919612
44. Achar ST, Rama Row GV. Clinical trials with dehydroemetine and paromomycin in acute amoebic dysentery in children. Journal of the Indian Medical Association 1967;49(8):370-2. 2919614
45. Ali Ata AH, el-Raziky ES. Trials of BT 436 in amoebiasis. Zeitschrift für Tropenmedizin und Parasitologie 1967;18(3):321-6. 2919616
46. Alterio DL. Clinico-parastilogological evaluation of an anti-ameba therapeutic activity of a new non-absorbable erythromycin stearate preparation [Avaliacao clinico-parasitologica da atividade terapeutica antiamebiana de uma nova preparacao de estearato de eritromicina nao absorvivel]. Hospital (Rio de Janeiro, Brazil) 1968;73(4):1207-13. 2919618
47. Amato Neto V, Wanderley RA. Use of an erythromycin stearate preparation of regulated intestinal release in the treatment of intestinal amebiasis [Observacoes preliminares sobre o emprego de preparacao de estearato de eritromicina, de liberacao intestinal regulada, no tratamento da amebiase intestinal]. Hospital (Rio de Janeiro, Brazil) 1968;73(2):583-9. 2919620
48. Apt W, Perez C, Gabor M, Doren G. Treatment of chronic amebiasis with nitrimidazole [Tratamiento de la amibiasis intestinal cronica con nimorazol]. Revista Medica de Chile 1976;104(11):791-3. 2919622
49. Apt W, Perez C, Miranda C, Gabor M, Doren G. Treatment of intestinal amebiasis and giardiasis with ornidazole [Tratamiento de la amebiasis intestinal y giardiasis con ornidazole]. Revista Medica de Chile 1983;111(11):1130-3. 2919624
50. Arredondo-Cortes E, Gonzalez-Gonzales JA, Bosques-Padilla F, Elizondo Riojos G, Barragan-Villareal. A randomized controlled trial of medical treatment vs medical treatment plus puncture in amoebic liver abscess [abstract]. Gut 1993;34(3):S43. 2919626
51. Atias A, Sapunar J, Parodi V, Perez C, Gabor M, Stagno S, et al. Treatment of chronic intestinal amebiasis with teclozan [Tratamiento de la amibiasis intestinal cronica con teclozan]. Boletin Chileno de Parasitologia 1972;27:119-21. 2919628
52. Bakshi JS, Ghiara JM, Nanivadekar AS. How does tinidazole compare with metronidazole? A summary report of Indian trials in amoebiasis and giardiasis. Drugs 1978;15 Suppl 1:133-42. 2919630
53. Banerjee RN, Singh J, Basu AK. Metronidazole in the treatment of amoebiasis. The Indian Practitioner 1976;29:208-16. 2919632
54. Baranski MC. Treatment of chronic intestinal amebiasis with the compound of diiodohydroxyquinoline, tetracycline and chloroquine [Tratamento da amebiase intestinal cronica pela associacao de diiohidroxiquinoleina, tetraciclina e cloroquina]. Revista Brasileira de Medicina 1966;23(11):774-8. 2919634
55. Barroso E, Ruiloba J. Treatment of intestinal amebiasis with eticlordifene [Tratamento de la amebiasis intestinal con eticlordifene]. Revista de Investigacion Clinica 1969;21(2):195-203. 2919636
56. Bassily S, Farid Z, El-Masry NA, Mikhail EM. Treatment of intestinal E. histolytica and G. lamblia with metronidazole, tinidazole and ornidazole: a comparative study. Journal of Tropical Medicine and Hygiene 1987;90(1):9-12. 2919638
57. Belkind-Valdovinos U, Belkind-Gerson J, Sanchez-Francia D, Espinoza-Ruiz MM, Lazcano-Ponce E. Evaluation of nitazoxanide in single dose and for three days in intestinal parasitism [Evaluacion de la nitazoxanida en dosis unica y por tres dias en parasitosis intestinal]. Salud Publica de Mexico 2004;46(3):333-40. 2919640
58. Bezjak B, Breitenfeld V. Mexaform in the treatment of amoebiasis [Mexaform in der amobiasis-therapie]. Munchener Medizinische Wochenschrift 1964;106(42):1946-6. 2919642
59. Bhatia S, Karnad DR, Oak JL. Randomized double-blind trial of metronidazole versus secnidazole in amebic liver abscess. Indian Journal of Gastroenterology 1998;17(2):53-4. 2919644
60. Biagi FF, Lopez RM, Gonzalez C, Gutierrez M. Chemoprophylaxis of amebiasis using clefamide in an open community [Quimoprofilaxis de la amibiasis con clefamida en una comunidad abierta]. Gaceta Medica de Mexico Sao Paolo 1966;96(2):183-90. 2919646
61. Biagi FF, Lopez RM, Gonzalez C, Gutierrez M. Chemoprophylaxis of amebiasis using clefamide in an open community [Quimoprofilaxis de la amibiasis con clefamida en una comunidad abierta]. Revista do Instituto de Medicina Tropical de São Paulo 1966;8(5):235-40. 2919647
62. Biagi F, Munoz J, Gonzalez C. Treatment of amoebiasis with drugs acting on intestinal lumen and tissue [Tratamiento de la amibiasis con medicamentos de accion luminal y tisular]. Prensa Medica Mexicana 1978;43(1-2):59-60. 2919649
63. Blanc F, Denjean B, Felix H, Nosny Y, Pene P, Renaud R. Trial treatment of amoebiasis by oral administration of 2-dehydroemetine [Essai de traitement de l'amibiase par l'administration orale de la 2-dehydroemetine]. Academie Nationale de Medecine La Presse Medicale 1965;149(16-17):360-5. 2919651
64. Blanc F, Denjean B, Felix H, Nosny Y, Pene P, Reynaud R, Sankale M. Treatment of amoebiasis with oral 2-dehydroemetine [Le traitement de l'amibiase par la 2-dehydroemetine orale]. La Presse Medicale 1966;74(2):51-4. 2919652
65. Blessman J, Tannich E. Treatment of asymptomatic intestinal Entamoeba histolytica infection. New England Journal of Medicine 2002;347(17):1384. 2919654
66. Blessman J, Binh HD, Hung DM, Tannich E, Burchard G. Treatment of amoebic liver abscess with metronidazole alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and randomized study. Tropical Medicine and International Health 2003;8(11):1030-4. 2919656
67. Botero D. Treatment of intestinal amoebiasis with diloxanide furoate, tetracycline and chloroquine. Transactions of the Royal Society of Tropical Medicine and Hygiene 1967;61(6):769-73. 2919658
68. Campos R. Treatment of intestinal amebiasis using erythromycin stearate under controlled release [Tratamento de amebiase intestinal pelo estearato de eritromicina de liberacao regulada]. Revista Brasileira de Medicina 1969;26(2):113-4. 2919660
69. Capparelli EV, Bricker-Ford R, Rogers MJ, McKerrow JH, Reed SL. Phase I clinical trial results of auranofin, a novel antiparasitic agent. Antimicrobial Agents and Chemotherapy 2016;61(1):pii: e01947-16. [DOI: 10.1128/AAC.01947-16]9828086
70. Cardoso Salles JM, Gundim Leitao E. Treatment of intestinal amebiasis using ethyl chlordiphene. Comparative study [Tratamento da amebiase intestinal com eticlordifene. Estudo comparativo]. Hospital (Rio de Janeiro, Brazil) 1970;77(6):2073-80. 2919662
71. Cariry NA, da Silva MA. Treatment of intestinal amoebiasis with teclozan (Falmonox). Comparative study of therapeutic schemes [Tratamento da amebiase intestinal com teclozan (Falmonox). Estudo comparativo de esquemas terapeuticos]. Hospital (Rio de Janeiro, Brazil) 1969;76(3):1033-7. 2919664
72. Chari MV, Gadiyar BN. A new drug (MK-910) in the therapy of intestinal and hepatic amebiasis. First results of clinical trial. American Journal of Tropical Medicine and Hygiene 1970;19(6):926-8. 2919666
73. Chaudhuri RN, Saha TK. Combined therapy of amoebic dysentery. Bulletin of the Calcutta School of Tropical Medicine 1966;14(1):22. 2919668
74. Cho KM, Cha HY, Soh CT. Clinical trials of R-0207 against Entamoeba histolytica infections (double blind trials versus metronidazole). Yonsei Reports on Tropical Medicine 1972;3:123-33. 2919670
75. Cohen HG, Reynolds TB. Comparison of metronidazole and chloroquine for the treatment of amoebic liver abscess. A controlled trial. Gastroenterology 1975;69(1):35-41. 2919672
76. da Cunha AS, da SIlva EF, de Mello SM. Clinical trial with the imidazol compound R.P. 14539 in intestinal amebiasis [Avaliacao terapeutico do composto imidazolico R.P. 14539 na amebiase intestinal]. Revista do Instituto de Medicina Tropical de São Paulo 1977;19(5):342-8. 2919674
77. Datta DV, Singh SA, Chhuttani PN. Treatment of amoebic liver abscess with emetine hydrochloride, niridazole, and metronidazole. A controlled clinical trial. American Journal of Tropical Medicine and Hygiene 1974;23(4):586-9. 2919676
78. de Carvalho HT, Coura LC, da Silva JR. Treatment of intestinal amebiasis - preliminary results of a trial with a new drug, Bayer 2456 (amebicide) [Tratamento da amebiase intestinal - resultados preliminares de ensaio com um novo medicamento, o Bayer 2456 (amoebacide)]. Revista Brasileira de Medicina 1965;22(9):562-6. 2919678
79. de la Rey Nel J, Simjee AE, Patel A. Indications for aspiration of amoebic liver abscess. South African Medical Journal 1989;75(8):373-6. 2919680
80. Delgado y Garnia R, Chavez-Esgueda JM. Etofamide in the treatment of children with acute intestinal amebiasis [Etofamida en el tratamiento de ninos con amibiasis intestinal aguda]. Prensa Medica Mexicana 1971;36(7-8):358-61. 2919682
81. da Oliveira CA. Therapeutic experience in the use of erythromycin stearate in chronic intestinal amebiasis [Experiencia terapeutica com estearato de eritromicina de liberacao regulada, na amebiase intestinal cronica]. Hospital (Rio de Janeiro, Brazil) 1969;76(1):175-8. 2919684
82. Devic J, Dosen H. Our initial experiences in the treatment of the intestinal amebiasis with 2-dehydroemetine. Medicinski Pregled 1974;27(1-2):79-83. 2919686
83. Dhariwal RK, Verma NP, Nioguy C, Pal SK, Singh SS, Chatterjee AK, et al. Clinical trial with entamide furoate in acute amebic dysentery. Indian Journal of Medical Science 1963;17:825-6. 2919688
84. Dinleyici EC, Eren M, Yargic ZA, Dogan N, Vandenplas Y. Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. American Journal of Tropical Medicine and Hygiene 2009;80(6):953-5. 2919690
85. Donckaster R, Sapunar J, Donoso A. Treatment of chronic intestinal amebiasis with tetracycline and chloroquine with bismuth glycoarsanilate and parasitological control by the combined telemann and polvinyl alcohol method [Ensayo terapeutico de la amibiasis intestinal cronica con tetraciclina y chloroquina glicolilarsanilato de bismuto y control parasitologico con los metodos de telemann y alcohol polivinilico combinados]. Boletin Chileno de Parasitologia 1957;12(2):24-9. 2919692
86. Doshi JC, Doshi MJ, Vaidya AB, Mehta JM, Sheth UK. Niridazole in amebic dysentery and hepatic amebiasis. American Journal of Tropical Medicine and Hygiene 1968;17(5):702-8. 2919694
87. dos Santos Moraise ML. Clinico-pathological results using erythromycin stearate in the treatment of intestinal amebiasis [Resultados clinico-parasitologicos obtidos com o uso do estearato de eritromicina de liberacao regulada no tratamento da amebiase intestinal]. Hospital (Rio de Janeiro, Brazil) 1969;75(4):1367-74. 2919696
88. Mofti A, Ayadi A. Trial of a new amoebicidal agent (chloro-hydroxyquinoline). Journal of the Egyptian Medical Association 1965;48(2):142-6. 2919698
89. Esquivel Lopez A, Gonzales Espinola G, Garcia Garduno JR, Guarner Dalias V. Various considerations in the treatment of amoebic liver abscess [Algunas consideraciones en el tratamiento del absceso hepatico amibiano]. Revista De Gastroenterologia De Mexico 1979;44(2):51-6. 2919700
90. Ey JL. Treatment of amoebiasis with metronidazole and entamide furoate. Ethiopian Medical Journal 1977;15:101-5. 2919702
91. Felix H, Freyria J, Maillard A. 2-dehydro-emetine administered per os in the treatment of amoebiasis. Therapeutical tests [La 2-dehydro-emetine administree par voie orale dans le traitement de l'amibiase. Essais therapeutiques]. Le Journal de Medecine de Lyon 1966;47(104):1211-6. 2919704
92. Felix H, Freyria J, Maillard A. Recent developments. 2-dehydro-emetine administered orally in the treatment of amoebiasis. Therapeutic trials (50 personal cases) [La 2-dehydro-emetine administree par voie orale dans le traitement de l'amibiase. Essais therapeutiques (a propos de 50 cas personnels)]. Archives Francaises des Maladies de l'Appareil Digestif 1966;55(10):909-14. 2919705
93. Freeman O, Akamaguna A, Jarikre LN. Amoebic liver abscess: the effect of aspiration on the resolution or healing time. Annals of Tropical Medicine and Parasitology 1990;84(3):281-7. 2919707
94. Gilman R, Islam M, Paschi S, Goleburn J, Ahmad F. Comparison of conventional and immunofluorescent techniques for the detection of Entamoeba histolytica in rectal biopsies. Gastroenterology 1980;78(3):435-9. 2919709
95. Gorbea Robles MC, Eternod JG, Velasquez FG, Cupido JD. Comparative study in intestinal amebiasis and giardiasis in infants and pre-school: efficacy and tolerance of secnidazole vs metronidazole and etofamide [Estudio comparativo en amebiasis y giardiasis intestinal del lactante y pre-escolar: eficacia y tolerancia del secnidazole vs metronidazol y etofamida]. Investigacion Medicina Inst 1989;16:79-82. 2919711
96. Hatchuel W. Tinidazole for the treatment of amoebic liver abscess. South African Medical Journal 1975;49(45):1879-81. 2919713
97. Hoekenga MT. A comparison of aureomycin and carbarsone in the treatment of intestinal amebiasis. American Journal of Tropical Medicine and Hygiene 1951;31(4):423-5. 2919715
98. Holz J. Comparison of natural and synthetical emetine as amebicide in children. Paediatrica Indonesiana 1965;5(3):793-801. 2919717
99. Huggins D. Treatment of amebiasis. Results obtained with diloxanide furoate [Tratamento da amebiase. Resultados obtidos com o furoato de diloxanida]. Revista do Instituto de Medicina Tropical de São Paulo 1965;7(2):110-1. 2919719
100. Huggins D. Clinical trial of a new salt: ethyl chordiphene, in the treatment of chronic intestinal amebiasis [Ensaio clinico com um novo sal: etil clordifene, no tratamento da amebiase intestinal cronica]. Anais da Escola Nacional de Saude Publica e de Medicina Tropical 1969;3(1):93-5. 2919721
101. Huggins D. Chemoprophylaxis of amebiasis: clinical trial with a new drug etophamide, in an open community [Quimoprofilaxia da amebiase, ensaio clinico com uma nova substancia-etofamida, em uma comunidade aberta]. Anais do Instituto de Higiene e Medicina Tropical 1974;2(1-4):545-51. 2919723
102. Huggins D. Clinical and chemoprophilatical trial with a new drug used against amebiasis in an open community [Ensaio clinico e quimoprofilatico com etofamida, uma substancia amebicida numa comunidade aberta]. Revista Brasiliera de Clinica e Terapeutica 1974;3(7):279-84. 2919724
103. Huggins D. Clinical test with teclozan in the treatment of amebic dysentery with a dose of 24 hours [Ensaio clinico com teclozan no tratamento da colite amebiana nao desinterica na dose de 24 horas]. Anais do Instituto de Higiene e Medicina Tropical 1977-1978;5(1-4):329-31. 2919726
104. Huggins D. Clinical trial of etophamide in the treatment of chronic intestinal amebiasis. G.E.N. 1980;34(1):51-4. 2919728
105. Huggins D. Clinical trials with RO 7-0207, ornidazole, in the treatment of chronic intestinal amebiasis [Ensaio clinico com Ro 7-0207, ornidazol, no tratamento da amebiase intestinal cronica]. Folha Medica 1981;82(4):445-6. 2919730
106. Irusen EM, Jackson TF, Simjee AE. Asymptomatic intestinal colonization by pathogenic Entamoeba histolytica in amebic liver abscess: prevalence, response to therapy, and pathogenic potential. Clinical Infectious Diseases 1992;14(4):889-93. 2919732
107. Islam N, Hasan M. Tinidazole in the treatment of intestinal amoebiasis. Current Therapeutic Research 1975;17(2):161-5. 2919734
108. Islam N, Hasan K. Tinidazole and metronidazole in hepatic amoebiasis. Drugs 1978;15 Suppl 1:26-9. 2919736
109. Islam N, Hasan M. Tinidazole and metronidazole in hepatic amoebiasis. Journal of Tropical Medicine and Hygiene 1978;81(1):20-2. 2919738
110. Jain NK, Madan A, Sharma TN, Sharma DK, Mandhana RG. Hepatopulmonary amoebiasis. Efficacy of various treatment regimens containing dehydroemetine and/or metronidazole. Journal of the Association of Physicians of India 1990;38(4):269-71. 2919740
111. Jayawickrema US, Lionel ND. Comparison of metronidazole with emetine and chloroquine in the treatment of hepatic amoebiasis - a controlled double blind study. Ceylon Medical Journal 1975;20(2):99-102. 2919742
112. Kahbazi M, Ebrahimi M, Zarinfar N, Arjomandzadegan M, Fereydouni T, Karimi F, Najmi AR. Efficacy of synbiotics for treatment of bacillary dysentery in children: a double-blind, randomized, placebo-controlled study. Advances in Medicine 2016;2016(3194010):1-6. 9828088
113. Kaur J, Mathur TN. Comparative drug trials in symptomatic and asymptomatic non-dysenteric amoebic colitis. Indian Journal of Medical Research 1972;60(10):1547-53. 2919744
114. Khalil HM, Fawzy AF, Sarwat MA. Trials of furazol and some other drugs in intestinal amoebiasis. Journal of the Egyptian Society of Parasitology 1987;17(2):417-25. 2919746
115. Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB. Comparative study of tinidazole and metronidazole in amoebic liver abscess. Current Medical Research and Opinion 1977;5(2):161-3. 2919748
116. Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB. Treatment of amoebic liver abscess with tinidazole and metronidazole. Drugs 1978;15 Suppl 1:23-5. 2919750
117. Konar NR, Mandal AK. Clinical trial of dehydroemetine in amoebiasis. Journal of the Indian Medical Association 1963;41(11):529-34. 2919752
118. Krishnaiah YSR, Muzib YI, Bhaskar P, Satyanarayana V, Latha K. Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of tinidazole in healthy human volunteers. Drug Delivery 2003;10(4):263-8. 2919754
119. Kurt O, Girginkardesler N, Balcioglu IC, Ozbilgin A, Ok UZ. A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clinical Microbiology and Infections 2008;14:601-4. 2919756
120. Laham E. Clinical trial of bismuth glycolyl arsenilate in intestinal amebiasis [Essai clinique du glycolyl arsenilate de bismuth dans l'amibiase intestinale]. Revue Medicale du Moyen-Orient 1951;8(1):96-9. 2919758
121. Levy A, Martinez AA, de Castro ML. Sustained release erythromycin stearate in the therapy of intestinal amebiasis [Estearatao de eritromicina de liberacao regulada no tratamento da amebiase intestinal]. Revista Brasileira de Medicina 1967;24(6):413-5. 2919760
122. Martinez AA, Levy A. Efficiency of the combination erythromycin-hexocylium in the treatment of dysentery syndromes [Eficacia da associacao eritromicina-hexociclio no tratamento de sindromes disentericas]. Revista Brasileira de Medicina 1969;26(12):759-62. 2919762
123. Masters DK, Hopkins AD. Therapeutic trials of four amoebicide regimens in rural Zaire. Journal of Tropical Medicine and Hygiene 1979;82(5):99-101. 2919764
124. Mathur TN, Kaur J. Non-dysenteric amoebic colitis treated with two grammes of metronidazole given as a single dose for two days. Indian Journal of Medical Research 1974;62(8):1208-11. 2919766
125. McAuley JB, Juranek DD. Paromomycin in the treatment of mild-to-moderate intestinal amebiasis. Clinical Infectious Diseases 1992;15(3):551-2. 2919768
126. McLeod C, Morris PS, Snelling TL, Carapetis JR, Bowen AC. Nitazoxanide for the treatment of infectious diarrhoea in the Northern Territory, Australia 2007-2012. Rural and Remote Health 2014;14(2):2759. 9828090
127. Mendis S, Dharmasena BD, Jayatissa SK. Comparison of tinidazole with metronidazole in the treatment of hepatic amoebiasis: a controlled double blind study. Ceylon Medical Journal 1984;29(2):97-100. 2919770
128. Misra NP, Laiq SM. Tinidazole in intestinal amoebiasis. Antiseptic 1976;73(7):371-3. 2919772
129. Misra NP, Laiq SM. Tinidazole in intestinal amoebiasis. Journal of the Association of Physicians of India 1976;24(4):231-5. 2919774
130. Montovani PAB, Pinto AMP, Santos MBD, Vieira DL, Prado AWD, Manfio JL. Bioavailability of two oral formulas of secnidazole in healthy volunteers. Brazilian Journal of Pharmaceutical Sciences 2009;45(4):687-92. 2919776
131. Morales-Mareles P, Suarez-Sanchez F, Boom RA. Random double blind comparison of intravenous metronidazole and intramuscular emetine in acute amebic liver abscess [Tratamiento doble ciego al azar con metronidazole i.v. o emetina i.m. en el absceso hepatico amibiano agudo]. Prensa Medica Mexicana 1975;40(3-4):124-6. 2919778
132. Murray MJ, Murray A, Murray CJ. The salutary effect of milk on amoebiasis and its reversal by iron. British Medical Journal 1980;280(6228):1351-2. 2919780
133. Muzaffar J, Madan K, Sharma MP, Kar P. Randomized, single-blind, placebo-controlled multicenter trial to compare the efficacy and safety of metronidazole and satranidazole in patients with amebic liver abscess. Digestive Disease Science 2006;51(12):2270-3. 2919782
134. Nahrevanian H, Assmar M. Cryptosporidiosis in immunocompromised patients in the Islamic Republic of Iran. Journal of Microbiology Immunology and Infection 2008;41:74-7. 2919784
135. Naik BK, Saboo RM. Quixalin. A drug trial. Journal of the Association of Physicians of India 1968;16(5):313-6. 2919786
136. Nanavati MB, Damany SJ, Joshi HD. Clinical trial of dehydroemetine (Ro 1-9334) in amoebiasis. Indian Practitioner 1965;18:259-63. 2919788
137. O'Holohan DR, Hugoe-Matthews JH. Single-dose and short course regimens of metronidazole in the treatment of amoebiasis in Malaysia. Annals of Tropical Medicine and Parasitology 1972;66(2):181-6. 2919794
138. Ohnishi K, Sakamoto N, Kobayashi K-I, Iwabuchi S, Nakamura-Uchiyama F, Ajisawa A, et al. Subjective adverse reactions to metronidazole in patients with amebiasis. Parasitology International 2014;63(5):698-700. 9828092
139. Okeniyi JA, Ogunlesi TA, Oyelami OA, Adeyemi LA. Effectiveness of dried Carica papaya seeds against human intestinal parasitosis: a pilot study. Journal of Medicine and Food 2007;10(1):194-6. 2919796
140. Olaeta Elizalde R, Perez Huacuja R, Najera Ruano A. Comparison of quinfamide versus etofamide in the Mexican population with intestinal amebiasis [Comparacion quinfamida vs etofamida en poblacion Mexicana con amibiasis intestinal]. Acta Gastroenterologica Latinoamericana 1996;26(5):277-80. 2919798
141. Omrani G, Rastegar-Lari A, Khamse M. Effect of single dose of secnidazole in treatment of intestinal amoebiasis. Journal of the Pakistan Medical Association 1995;45(6):159. 2919800
142. Orozco Garcia O, Perez Nava J, Gonzalez Diaz R. Clinical evaluation of nimorazole in amebic liver abscess (author's transl)]. Prensa Medica Mexicana 1975;40(11-12):378-82. 2919802
143. Padilla N, Figueroa R, Rivera MR, Guerrero S. Comparative study in quinfamide and etofamide in the treatment of asymptomatic amoebic infection [Estudio comparativo entre quinfamida y etofamida en el tratamiento de la infección amibiana asintomática]. Revista Mexicana de Pediatría 1995;62(1):5-7. 2919804
144. Padilla-Raygoza N, Alarcon-Ginori A, Figueroa-Ferrari RC, Munoz-Rodriguez M. Comparison of the effect of quinfamide and nitazoxanide in the treatment of nondysenteric intestinal amebiasis in children [Comparacion del efecto de la quinfamida y de la nitazoxanida en el tratamento de la amibiasis intestinal no disenterica en ninos]. Revista Mexicana de Pediatria 1998;65(5):196-9. 2919806
145. Padilla N, Diaz R, Alarcon A, Barreda R. Antiamoebic chemoprophylaxis using quinfamide in children: a comparative study. Scientific World Journal 2002;2:1070-8. 2919808
146. Pang X, Zhang Y, Gao R, Zhong K, Zhong D, Chen X. Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy Chinese subjects. Antimicrobial Agents and Chemotherapy 2014;58(10):5987-5993. 9828094
147. Pimparkar BD, Raghavan P, Satoskar RS. A clinical trial of 1-dichloroacetyl-4-methylpiperidine (R.D. 7098), a new anti-amoebic drug. Transactions of the Royal Society of Tropical Medicine and Hygiene 1966;60(2):237-40. 2919810
148. Populaire P, Decouvelaere B, Renard A, Pasquier P. Study of seric concentrations and urinary excretion of secnidazole after oral administration in man. Comparison with tinidazole [Etude des taux seriques et de l'elimination urinaire du secnidazole apres administration orale chez l'homme comparaison avec le tinidazole]. Pathologie et Biologie 1980;28(9):621-4. 2919812
149. Powell SJ, MacLeod I, Wilmot AJ, Elsdon-Dew R. The treatment of acute amoebic dysentery: trials of dehydroemetine, of dehydroemetine-bismuth-iodide, and of dehydroemetine and dehydroemetine-bismuth-iodide in combination. Annals of Tropical Medicine and Parasitology 1965;59:205-7. 2919814
150. Powell SJ, Wilmot AJ, Macleod IN, Elsdon-Dew R. A comparative trial of dehydroemetine, emetine hydrochloride and chloroquine in the treatment of amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1965;59(4):496-9. 2919816
151. Powell SJ, Wilmot AJ, Macleod IN, Elsdon-Dew R. Dehydroemetine in the treatment of amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1965;59(2):208-9. 2919818
152. Powell SJ, MacLeod I, Wilmot AJ, Elsdon-Dew R. Further drug trials in acute amoebic dysentery: demethylchlortetracycline, methacycline, ampicillin and chlorhydroxyquinoline. Transactions of the Royal Society of Tropical Medicine and Hygiene 1965;59(6):709-11. 2919820
153. Powell SJ, MacLeod I, Wilmot AJ, Elsdon-Dew R. Ambilhar in amoebic dysentery and amoebic liver abscess. Lancet 1966;i:20-2. 2919822
154. Powell SJ, MacLeod I, Wilmot AJ, Elsdon-Dew R. Late release oral dehydroemetine in acute amoebic dysentery. Journal of Tropical Medicine and Hygiene 1966;69:153-4. 2919824
155. Powell SJ, Wilmot AJ, MacLeod I, Elsdon-Dew R. The effect of a nitro-thiazole derivative, Ciba 32, 644-Ba, in amebic dysentery and amebic liver abscess. American Journal of Tropical Medicine and Hygiene 1966;15(3):300-2. 2919826
156. Powell SJ, Wilmot AJ, Macleod IN, Elsdon-Dew R. A comparative trial of dehydroemetine and emetine hydrochloride in identical dosage in amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1967;61(1):26-8. 2919828
157. Powell SJ. Metronidazole in the treatment of amoebic dysentery. Indian Practitioner 1968;21:696-700. 2919830
158. Powell SJ, Wilmot AJ, Elsdon-Dew R. Single and low dosage regimens of metronidazole in amoebic dysentery and amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1969;63(2):139-42. 2919832
159. Powell SJ, Wilmot AJ, Elsdon-Dew R. The use of niridazole alone and in combination with other amoebicides in amoebic dysentery and amoebic liver abscess. Annals of the New York Academy of Science 1969;160(2):749-54. 2919834
160. Powell SJ. Drug trials in amoebiasis. Bulletin of the World Health Organization 1969;40(6):956-8. 2919836
161. Powell SJ, Elsdon-Dew R. Evaluation of metronidazole and MK910 in invasive amebiasis. American Journal of Tropical Medicine and Hygiene 1971;20(6):839-41. 2919838
162. Powell SJ, Elsdon-Dew R. Chloroquine in amoebic dysentery. Transactions of the Royal Society of Tropical Medicine and Hygiene 1971;65(4):540. 2919840
163. Powell SJ, Elsdon-Dew R. Some new nitroimidazole derivatives. Clinical trials in amebic liver abscess. American Journal of Tropical Medicine and Hygiene 1972;21(5):518-20. 2919842
164. Powell SJ. Latest developments in the treatment of amebiasis. Advances in Pharmacology and Chemotherapy 1972;10:91-103. 2919844
165. Powell SJ, Rubidge CJ, Elsdon-Dew R. Clinical trials of benzoyl metronidazole suspension in amoebic dysentery and amoebic liver abscess. South African Medical Journal 1973;47(12):507-8. 2919846
166. Prakash C, Bansal BC, Bansal MR. A comparative study of tinidazole and metronidazole in symptomatic intestinal amoebiasis. Journal of the Association of Physicians of India 1974;22(7):527-9. 2919848
167. Qureshi H, Baqai B, Zuberi SJ, Ahmed W, Qureshi SA. Efficacy of secnidazole in the treatment of intestinal amoebiasis. Journal of the Pakistan Medical Association 1994;44(4):93-4. 2919850
168. Qureshi H, Ali A, Baqai R, Ahmed A. Efficacy of a combined diloxanide furoate-metronidazole preparation in the treatment of amoebiasis and giardiasis. Journal of International Medical Research 1997;25(3):167-70. 2919852
169. Rodrigues LD, Jafferian PA, Villela MdeP, de Mello EB. Comparative study on 3 amebicides: teclozine, clefamide and a combination of clefamide and iodo-chloro-oxyquinolines and streptomycin [Estudo comparativo de tres amebicidas: o teclozine, a clefamida e a associacao de clefamida com iodo-cloro-oxiquinoleina e estreptomicina]. Hospital (Rio de Janeiro, Brazil) 1968;74(5):1563-73. 2919854
170. Ruas A, Correia MH, Valle JC do, Ribeiro JA. RO 7-0207 in amoebic liver abscess. Comparative study of the effects of RO 7-0207 and metronidazole. Central African Journal of Medicine 1973;19(6):128-32. 2919856
171. Ruchko AF. Clinical and treatment characteristics of amebiasis in children in a hot climate. Pediatriia, Akusherstvo i Ginekologiia 1978;Sept-Oct(5):28-9. 2919858
172. Saha TK, Chaudhuri RN. Clinical trial of furoxone in amoebic dysentery. Bulletin of the Calcutta School of Tropical Medicine 1966;14(1):22. 2919860
173. Saha TK, Mandal JN. Niridazole in amoebic dysentery. Journal of the Indian Medical Association 1970;55(4):127-9. 2919862
174. Salem HH, Rabbo HA. Clinical trials with dehydroemetine dihydrochloride in the treatment of acute amoebiasis. Journal of Tropical Medicine and Hygiene 1964;67:137-41. 2919864
175. Salem SN. Clinical trial of oral dehydroemetine in intestinal amoebiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1967;61(6):774-5. 2919866
176. Sandia OG, Dobbins Filho J, Leite IC, Harris PB. Comparative therapeutic trial of ornidazole and metronidazole in chronic amebiasis [Ensaio terapeutico comparativo entre ornidazole e metronidazol em amebiase cronica]. Revista do Instituto de Medicina Tropical de São Paulo 1977;19(1):52-6. 2919868
177. Sangiuolo F. Antimicrobial and antispastic effect of a combination of canulase and iodochloroxyquinoline (Septo-canulase) in various acute and chronic enteropathies [Sull'azione antimicrobica ed antispastica di una associazione di canulase con iodoclorossichinolina (Septo-canulase) in alcune enteropatie acute e croniche]. Rassegna Internazionale di Clinica e Terapia 1969;49(19):1231-50. 2919870
178. Sankale M, Moulanier M. Treatment of amebiasis with oral dehydroemetine [Le traitement de l'amibiase par la dehydroemetine orale]. Therapie 1966;21(3):733-41. 2919872
179. Sankale M, Satge P, Lariviere M, Moulanier M, Bourgeade A, Debroise C, et al. Efficacy of niridazole in amoebic dysentery. Annals of the New York Academy of Science 1969;160(2):755-63. 2919874
180. Sankale M, Coly D, Niang I. Treatment of amoebiasis with a drinkable suspension of metronidazole [Traitement de l'amibiase par une suspension buvable de metronidazole]. Therapie 1974;29:411-5. 2919876
181. Satpathy BK, Acharya SK, Satpathy S. Comparative study of intravenous metronidazole and intramuscular dehydroemetine in amoebic liver abscess. Journal of the Indian Medical Association 1988;86(2):38-40. 2919878
182. Schapiro MM. Intestinal amebiasis. A preliminary clinical trial of furamide T/c. American Journal of Tropical Medicine and Hygiene 1967;16(6):704-7. 2919880
183. Scragg JN, Powell SJ. Emetine hydrochloride and dehydroemetine combined with chloroquine in the treatment of children with amoebic liver abscess. Archives of Disease in Childhood 1968;43(227):121-3. 2919882
184. Scragg JN, Powell SJ. Metronidazole and niridazole combined with dehydroemetine in treatment of children with amoebic liver abscess. Archives of Disease in Childhood 1970;45(240):193-5. 2919884
185. Segal J. Clinico-paracytological and therapeutic study with a new preparation of erythromycin stearate of controlled release (A-16535) [Estudo clinico-parasitologico e terapeutico com uma nova preparacao de estearato de eritromicina de liberacao regulada (A-16535)]. Revista Brasileira de Medicina 1967;24(8):626-32. 2919886
186. Sharif A, Kashani HH, Nasri E, Soleimani Z, Sharif MR. The role of probiotics in the treatment of dysentery: a randomized double-blind clinical trial. Probiotics and Antimicrobial Proteins 2017;21:1-6 [Epub ahead of print]. [DOI: 10.1007/s12602-017-9271-0]9828096
187. Sharma MP, Rai RR, Acharya SK, Ray JC, Tandon BN. Needle aspiration of amoebic liver abscess. BMJ 1989;299(6711):1308-9. 2919888
188. Shrotriya V, Dabral SB, Maheshwari BB, Gupta SC, Maheshwari BB. A controlled trial of Diarex and tinidazole in chronic intestinal amoebiasis. Medicine and Surgery 1985;25(1):8-9, 16. 2919890
189. Simjee AE, Gathiram V, Jackson TF, Khan BF. A comparative trial of metronidazole v. tinidazole in the treatment of amoebic liver abscess. South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde 1985;68(13):923-4. 2919892
190. Simon M, Shookhoff HB, Terner H, Weingarten B, Parker JG. Paromomycin in the treatment of intestinal amebiasis; a short course of therapy. American Journal of Gastroenterology 1967;48(6):504-11. 2919894
191. Sinuhaji AB, Lubis CP, Daulay HRM, Lubis IT, Jufri A, Sutanto AH. A double-blind trial between metronidazole and secnidazole in acute amebic dysentery in children (Preliminary Report). Paediatrica Indonesiana 1986;26:9-14. 2919896
192. Sladden DL, Taylor E, Livingstone DJ. A clinical trial of a new compound (dehydroemetine bismuth iodide, Ro 4, 3076) in amoebic dysentery. Central African Journal of Medicine 1964;10(11):412-3. 2919898
193. Soh CT, Cho MJ, Choi HJ, Hur JD. Double blind test of ornidazole versus tinidazole against amoebic liver abscess. Yonsei Reports on Tropical Medicine 1980;11(1):43-50. 2919900
194. Speich B, Marti H, Ame SM, Ali SM, Bogoch II, Utzinger J, Albonico M, et al. Prevalence of intestinal protozoa infection among school-aged children on Pemba Island, Tanzania, and effect of single-dose albendazole, nitazoxanide and albendazole-nitazoxanide. Parasites & Vectors 2013;6(3):1-8. 2919902
195. Spellberg MA. Treatment of amoebic liver abscess. American Journal of Gastroenterology 1969;51(4):298-302. 2919904
196. Spillman R, Ayala SC, Sanchez CE. Double blind test of metronidazole and tinidazole in the treatment of asymptomatic Entamoeba histolytica and Entamoeba hartmanni carriers. American Journal of Tropical Medicine and Hygiene 1976;25(4):549-51. 2919906
197. Sutrisno D, Ismail D, Sebodo T, Ismangun, Noerhajati S. Nitrimidazine (Naxogin) in the treatment of children with intestinal amoebiasis. Paediatrica Indonesiana 1978;18(7-8):217-23. 2919908
198. Tandon A, Jain AK, Dixit VK, Agarwal AK, Gupta JP. Needle aspiration in large amoebic liver abscess. Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 1997;18(1):19-21. 2919910
199. Thompson CN, Phan MVT, Van Minh Hoang N, Van Minh P, Vinh NT, Thuy CT, et al. A prospective multi-center observational study of children hospitalized with diarrhea in Ho Chi Minh City, Vietnam. American Journal of Tropical Medicine and Hygiene 2015;92(5):1045-52. 9828098
200. Thoren K, Hakansson C, Bergstrom T, Johnaisson G, Norkrans G. Treatment of asymptomatic amebiasis in homosexual men. Clinical trials with metronidazole, tinidazole, and diloxanide furoate. Sexually Transmitted Diseases 1990;17(2):72-4. 2919912
201. Thoren K, Hakansson C, Bergstrom T, Johnaisson G, Norkrans G. Treatment of asymptomatic amoebiasis in homosexual men: clinical trials with metronidazole, tinidazole and diloxanide furoate [abstract]. Genitourinary Medicine 1990;66(5):411. 2919914
202. Tjaij JK, Raid N, Irawati T, Siregar D, Kwo IT, Tan BE. Mexaform and entobex therapy in amebic dysentery. Paediatrica Indonesiana 1969;9(5):210-4. 2919916
203. Tjaij JK, Raid N, Sutanto AH. Clinical trials of oral dehydro-emetine tablets (Ro 1-9334/10) in amebic dysentery in children. Paediatrica Indonesiana 1970;10(4):139-48. 2919918
204. Vaidya AB, Ray DK, Mankodi NA, Paul T, Sheth UK. Phase I tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2-imidazolyl)-2-imidazolidinone (Go 10213): a new antiprotozoal agent. British Journal of Clinical Pharmacology 1983;16(5):517-22. 2919920
205. Vakil BJ, Shah SC, Moses JM. The comparative value of dehydroemetine and emetine in amebiasis. Journal of the Association of Physicians of India 1967;15(5):223-8. 2919922
206. Vakil BJ, Dalal AJ, Mehta AJ, Mody NC. Clinical evaluation of oral dehydroemetine in amoebiasis. Journal of the Association of Physicians of India 1971;19(5):403-8. 2919924
207. Vakil BJ, Dalal NJ. Comparative evaluation of amoebicidal drugs. Progress in Drug Research 1974;18:353-64. 2919926
208. Valencia-Parparcen J. Erythromycin in the treatment of intestinal amebiasis and other processes of the digestive tract [La eritromicina en el tratamiento de la amibiasis intestinal y otros procesos del tubo digestivo]. G.E.N. 1973;28(1):29-37. 2919928
209. Vanijanonta S, Bunnag D, Looareesuwan S, Harinasuta T. Low dose tinidazole in the treatment of amoebic liver abscess. Southeast Asia Journal of Tropical Medicine and Public Health 1985;16(2):253-6. 2919930
210. Viswanathan M, Krishnaswami CV. Therapeutic trials with oral dehydroemetine in intestinal amoebiasis. Journal of the Indian Medical Association 1968;51(8):381-3. 2919932
211. Waddington CS, McLeod C, Morris P, Bowen A, Naunton M, Carapetis J, et al. The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children. BMJ Open 2018;8:e019632. [DOI: 10.1136/bmjopen-2017-019632]9828100
212. Wang LT, Sung JL. Trials of metronidazole in amebic dysentery and amebic liver abscess. Taiwan Yi Xue Hue Za Zhi 1971;70(7):405-8. 2919934
213. Wang LT, Yang SP. Studies on oxytetracycline resistant amebic dysentery. Taiwan Yi Xue Hue Za Zhi 1971;70(3):131-4. 2919936
214. Watson PG. Amoebic infection of the eye. Transactions of the Ophthalmological Societies of the United Kingdom 1975;95(2):204-6. 2919938
215. Welch JS, Rowsell BJ, Freeman C. Treatment of intestinal amoebiasis and giardiasis. Efficacy of metronidazole and tinidazole compared. Medical Journal of Australia 1978;1(9):469-71. 2919940
216. Widjaya P, Bilic A, Babic Z, Ljubicic N, Bakula B, Pilas V. Amoebic liver abscess: ultrasonographic characteristics and results of different therapeutic approaches. Acta Medica Iugoslavica 1991;45(1):15-21. 2919942
217. Wilmot AJ, Powell SJ, MacLeod I, Elsdon-Dew R. Paromomycin in acute amoebic dysentery. Annals of Tropical Medicine and Parasitology 1962;56:383-6. 2919944
218. Wolfe MS. Nondysenteric intestinal amoebiasis. JAMA 1973;224(12):1601-4. 2919946
219. Wolfensberger HR. Amoebiasis: clinical trials of dehydroemetine late-release tablets (Ro 1-9334/20) compared with parenteral dehydroemetine and niridazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 1968;62(6):831-7. 2919948
220. Zuberi SJ, Ibrahim M. Tinidazole in amoebiasis. Practitioner 1973;211:93-5. 2919950
221. National Institute of Allergy and Infectious Diseases (NIAID). Phase IIa Randomized, Single-blinded, Placebo-controlled Clinical Trial of the Reprofiled Drug Auranofin for GI Protozoa. clinicaltrials.gov Last Update Posted: September 15, 2017. [ClinicalTrials.gov identifier: NCT02736968]9828102
222. Drug Use Investigation of Paromomycin. clinicaltrials.gov Last update posted: March 6, 2018. [ClinicalTrials.gov identifier NCT02680665 ]9828104
223. American Academy of Pediatrics. Amebiasis. In: Kimberlin DW, Brady MT, Jackson MA, Long SS editor(s). Red Book: 2015 Report of the Committee on Infectious Diseases. 30th Edition. Elk Grove Village, IL: American Academy of Pediatrics, 2012:228-30.
224. Abd-Alla MD, Ravdin JI. Diagnosis of amoebic colitis by antigen capture ELISA in patients presenting with acute diarrhoea in Cairo, Egypt. Tropical Medicine and International Health 2002;7(4):365-70.
225. Adagu IS, Nolder D, Warhurst DC, Rossignol JF. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica, and Trichomonas vaginalis. Journal of Antimicrobial Chemotherapy 2002;49:103-11.
226. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD003048.pub3]
227. Bansal D, Sehgal R, Chawla Y, Malla N, Mahajan RC. Multidrug resistance in amoebiasis patients. Indian Journal of Medical Research 2006;124(2):189-94.
228. Barwick RS, Uzicanin A, Lareau S, Malakmadze N, Imnadze P, Iosava M, et al. Outbreak of amebiasis in Tbilisi, Republic of Georgia, 1998. American Journal of Tropical Medicine and Hygiene 2002;67(6):623-31.
229. Bercu TE, Petri WA, Behm JW. Amebic colitis: new insights into pathogenesis and treatment. Current Gastroenterology Reports 2007;9(5):429-33.
230. Blessman J, Ali IKM, Ton Nu PA, Dinh BT, Ngo Viet TQ, Van AL, et al. Longitudinal study of intestinal Entamoeba histolytica infections in asymptomatic adult carriers. Journal of Clinical Microbiology 2003;41(10):4745-50.
231. Braga LL, Lima AAM, Sears CL, Newman RD, Wuhib T, Paiva CA, et al. Seroepidemiology of Entamoeba histolytica in a slum in Northeastern Brazil. American Journal of Tropical Medicine and Hygiene 1996;55(6):693-7.
232. Braga LL, Mendonca Y, Paiva CA, Sales A, Cavalcante ALM, Mann BJ. Seropositivity for and intestinal colonization with Entamoeba histolytica and Entamoeba dispar in individuals in Northeastern Brazil. Journal of Clinical Microbiology 1998;36(10):3044-5.
233. Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. British Medical Journal 2005;331(7521):897-900.
234. CatalaLepez F, Tobias A, Cameron C, Moher D, Hutton B. Network metaanalysis for comparing treatment effects of multiple interventions: an introduction. Rheumatology International 2014;34(11):1489-96.
235. CDC. Laboratory diagnosis of amebiasis: Entamoeba histolytica and Entamoeba dispar. CDC, Atlanta, GA, 2010. http://www.cdc.gov/dpdx/resources/pdf/benchAids/entamoeba_benchaid.pdf (accessed 12 April 2015).
236. Cedillo-Rivera R, Chavez B, Gonzales-Robles A, Tapia A, Yepez-Mulia L. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis, and Trichomonas vaginalis trophozoites. Journal of Eukaryotic Microbiology 2002;49(3):201-8.
237. Chen Y, Zhang Y, Yang B, Qi T, Lu H, Cheng X, Tachibana H. Seroprevalence of Entamoeba histolytica infection in HIV infected patients in China. American Journal of Tropical Medicine and Hygiene 2007;77:825-8.
238. Choudhuri G, Rangan M. Amebic infection in humans. Indian Journal of Gastroenterology 2012;31(4):153-62.
239. Dans L, Martinez E. Amoebic dysentery. Clinical Evidence 2006;15:1007-13.
240. Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J. Laboratory diagnostic techniques for Entamoeba species. Clinical Microbiology Reviews 2007;20:511-32.
241. Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clinical Infectious Diseases 2005;40:1173-80.
242. Gathiram V, Jackson TFHG. A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica. South African Medical Journal 1987;72:669-72.
243. Gatti S, Swierczynski G, Robinson F, Anselmi M, Corrales J, Moreira J, et al. Amebic infections due to the Entamoeba histolytica-Entamoeba dispar complex: a study of the incidence in a remote rural area of Ecuador. American Journal of Tropical Medicine and Hygiene 2002;67(1):123-7.
244. Goldenberg JZ, Ma SSY, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD006095.pub3]
245. GRADE Working Group. Grading quality of evidence and strength of recommendations. British Medical Journal 2004;328(1490):1-8.
246. Gunther J, Shafir S, Bristow B, Sorvillo F. Short report: amebiasis-related mortality among United States residents, 1990-2007. American Journal of Tropical Medicine and Hygiene 2011;85(6):1038-40.
247. Haque R, Faruque ASG, Hahn P, Lyerly DM, Petri WA Jr. Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh. Journal of Infectious Diseases 1997;175(3):734-6.
248. Haque R, Ali IKM, Akther S, Petri WA Jr. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection. Journal of Clinical Microbiology 1998;36(2):449-52.
249. Haque R, Ali IM, Petri WA Jr. Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh. American Journal of Tropical Medicine and Hygiene 1999;60(6):1031-4.
250. Haque R, Ali IM, Sack RB, Farr BM, Ramakrishnan G, Petri WA Jr. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. Journal of Infectious Diseases 2001;183(12):1787-93.
251. Haque R, Duggal P, Ali IM, Hossain MB, Mondal D, Sack RB, et al. Innate and acquired resistance to amebiasis in Bangladeshi children. Journal of Infectious Diseases 2002;186(4):547-52.
252. Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr. Amebiasis. New England Journal of Medicine 2003;348(16):1565-73.
253. Hayat F, Azam A, Shin D. Recent progress on the discovery of antiamoebic agents. Bioorganic & Medicinal Chemistry Letters 2016;26(21):5149-59.
254. Herbinger KH, Fleischmann E, Weber C, Perona P, Löscher T, Bretzel G. Epidemiological, clinical, and diagnostic data on intestinal infections with Entamoeba histolytica and Entamoeba dispar among returning travelers. Infection 2011;39(6):527-35.
255. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2008.
256. Higgins JPT, Altman DG, Sterne JAC, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
257. Hung CC, Ji DD, Sun HY, Lee YT, Hsu SY, Chang SY, et al. Increased risk for Entamoeba histolytica infection and invasive amebiasis in HIV seropositive men who have sex with men in Taiwan. PLoS Neglected Tropical Diseases 2008;2(2):e175.doi:10.1371/journal.pntd.0000175.
258. James R, Barratt J, Marriott D, Harkness J, Stark D. Short report: seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia. American Journal of Tropical Medicine and Hygiene 2010;83(4):914-6.
259. Kappagoda S, Singh U, Blackburn BG. Antiparasitic therapy. Mayo Clinic Proceedings 2011;86(6):561-83.
260. Lamp KC, Freeman CD, Klutman NE, Lacy MK. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clinical Pharmacokinetics 1999;36(5):353-73.
261. Lee KC, Lu CC, Hu WS, Lin SE, Chen HH. Colonoscopic diagnosis of amebiasis: a case series and systematic review. International Journal of Colorectal Disease 2015;30(1):31-41.
262. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
263. Li E, Stanley SL Jr. Parasitic diseases of the liver and intestines. Gastroenterology Clinics 1996;25(3):471-92.
264. Looke DFM. Metronidazole and tinidazole compared. Australian Prescriber 1987;10(2):35-7.
265. Mackey-Lawrence N, Petri Jr WA. Amoebic dysentery. BMJ Clinical Evidence 2011;2011:0918.
266. Marie C, Petri WA Jr. Amoebic dysentery. BMJ Clinical Evidence 2013;2013:0918.
267. Mondal D, Petri WA, Sack RB, Kirkpatrick BD, Haque R. Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006;100(11):1032-8.
268. Monro AM. Blood levels of chemotherapeutic drugs and the pharmacokinetics of tinidazole and metronidazole. Current Medical Research and Opinion 1974;2(3):130-6.
269. Morfl L, Singh U. Entamoeba histolytica: a snapshot of current research and methods for genetic analysis. Current Opinion in Microbiology 2012;15(4):469-75.
270. Nagata N, Shimbo T, Akiyama J, Nakashima R, Nishimura S, Yada T, et al. Risk factors for intestinal invasive amebiasis in Japan, 2003-2009. Emerging Infectious Diseases 2012;18(5):717-24.
271. Nagpal I, Raj I, Subbarao N, Gourinath S. Virtual screening, identification and in vitro testing of novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolytica. PLoS One 2012;7(2):e30305. [DOI: 10.1371/journal.pone.0030305]
272. Nesbitt RA, Mosha FW, Katki HA, Ashraf M, Assenga C, Lee CM. Amebiasis and comparison of microscopy to ELISA technique in detection of Entamoeba histolytica and Entamoeba dispar. Journal of the National Medical Association 2004;96(5):671-7.
273. Ochoa TJ, White AC Jr. Nitazoxanide for treatment of intestinal parasites in children. Pediatric Infectious Disease Journal 2005;24(7):641-2.
274. Okamoto M, Kawabe T, Ohata K, Togo G, Hada T, Katamoto T, et al. Amebic colitis in asymptomatic subjects with positive fecal occult blood test results: clinical features different from symptomatic cases. American Journal of Tropical Medicine and Hygiene 2005;73(5):934-5.
275. Parashar A, Arya R. Nitazoxanide. Indian Pediatrics 2005;42:1161-5.
276. Park WB, Choe PG, Jo JH, Kim SH, Bang JH, Kim HB, et al. Amebic liver abscess in HIV-infected patients, Republic of Korea. Emerging Infectious Diseases 2007;13:516-7.
277. Petri WA. Therapy of intestinal protozoa. Trends in Parasitology 2003;19(11):523-6.
278. Petri WA Jr, Mondal D, Peterson KM, Duggal P, Haque R. Association of malnutrition with amebiasis. Nutrition Reviews 2009;67(Suppl 2):S207-15.
279. Petri WA Jr, Haque R. Entamoeba species, including amoebiasis. In: Mandell GL, Bennett JE, Dolin R editor(s). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th Edition. Philadelphia, PA: Churchill Livingstone Elsevier, 2010:3411-25.
280. Ralston KS, Petri WA Jr. Tissue destruction and invasion by Entamoeba histolytica. Trends in Parasitology 2011;27(6):254-63.
281. Ramos F, Moran P, Gonzalez E, Garcia G, Ramiro M, Gomez A, et al. High prevalence rate of Entamoeba histolytica asymptomatic infection in a rural Mexican community. American Journal of Tropical Medicine and Hygiene 2005;73(1):87-91.
282. Ravdin JI. Entamoeba histolytica (Amebiasis). In: Mandell GL, Bennett JE, Dolin R editor(s). Principles and Practice of Infectious Diseases. 6th Edition. Philadelphia: Churchill Livingstone, 2005:3097-3111.
283. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
284. Rivera WL, Tachibana H, Kanbara H. Field study on the distribution of Entamoeba histolytica and Entamoeba dispar in the Northern Philippines as detected by the polymerase chain reaction. American Journal of Tropical Medicine and Hygiene 1998;59(6):916-21.
285. Rivera WL, Santos SR, Kanbara H. Prevalence and genetic diversity of Entamoeba histolytica in an institution for the mentally retarded in the Philippines. Parasitology Research 2006;98:106-10.
286. Salit IE, Khairnar K, Gough K, Pillai DR. A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strain. Clinical Infectious Diseases 2009;49:346-53.
287. Samarawickrema NA, Brown DM, Upcroft JA, Thammapalerd N, Upcroft P. Involvement of superoxide dismutase and pyruvate: ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. Journal of Antimicrobial Chemotherapy 1997;40(6):833-40.
288. Samie A, Obi LC, Bessong PO, Stroup S, Houpt E, Guerrant RL. Prevalence and species distribution of E. histolytica and E. dispar in the Venda Region, Limpopo, South Africa. American Journal of Tropical Medicine and Hygiene 2006;75(3):565-71.
289. Shirley D-A, Moonah S. Fulminant amebic colitis after corticosteroid therapy: a systematic review. PLoS Neglected Tropical Diseases 2016;10(7):e0004879. [DOI: 10.1371/journal.pntd.0004879]
290. Shirley DT, Farr L, Watanabe K, Moonah S. A review of the global burden, new diagnostics, and current therapeutics for amebiasis. Open Forum Infectious Diseases 2018;5(7):ofy161. [DOI: 10.1093/ofid/ofy161]
291. Stanley SL Jr. Amoebiasis. Lancet 2003;361(9362):1025-34.
292. Stark D, van Hal SJ, Matthews G, Harkness J, Marriott D. Invasive amebiasis in men who have sex with men, Australia. Emerging Infectious Diseases 2008;14:1141-3.
293. Talamás-Lara D, Chávez-Munguía B, González-Robles A, Talamás-Rohana P, Salazar-Villatoro L, Durán-Díaz Á, et al. Erythrophagocytosis in Entamoeba histolytica and Entamoeba dispar: a comparative study. BioMed Research International 2014;2014:626259.
294. Tanyuksel M, Petri WA Jr. Laboratory diagnosis of amebiasis. Clinical Microbiology Reviews 2003;16(4):713-29.
295. Tanyuksel M, Yilmaz H, Ulukanligil M, Araz E, Cicek M, Koru O, et al. Comparison of two methods (microscopy and enzyme-linked immunosorbent assay) for the diagnosis of amebiasis. Experimental Parasitology 2005;110(3):322-6.
296. Tarleton JL, Haque R, Mondal D, Shu J, Farr BM, Petri WA Jr. Cognitive effects of diarrhea, malnutrition, and Entamoeba histolytica infection on school age children in Dhaka, Bangladesh. American Journal of Tropical Medicine and Hygiene 2006;74(3):475-81.
297. The Medical Letter. Drugs for parasitic infections. 3rd edition. 2013. https://secure.medicalletter.org/article-share?a=143a&p=tg&title=Drugs%20for%20Parasitic%20Infections&cannotaccesstitle=1 (accessed 1 September 2017).
298. Tracy JW, Webster LT Jr. Drugs used in the chemotherapy of protozoal infections: amebiasis, giardiasis, trichomoniasis, leishmaniasis, and other protozoal infections. In: Hardman JG, Limbird LE, Goodman Gilman A editor(s). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th Edition. New York: McGraw Hill Medical Publishing Division, 2001:1097-1120.
299. Tsai JJ, Sun HY, Ke LY, Tsai KS, Chang SY, Hsieh SM, et al. Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus Type 1 infection in Taiwan. American Journal of Tropical Medicine and Hygiene 2006;74:1016-9.
300. Verkerke HP, Petri WA, Marie CS. The dynamic interdependence of amebiasis, innate immunity, and undernutrition. Seminars in Immunopathology 2012;34(6):771-85.
301. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Reviews of Infectious Disease 1986;8(2):228-38.
302. Wassman C, Hellberg A, Tannich E, Bruchhaus I. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. Journal of Biological Chemistry 1999;274(37):26051-6.
303. Watanabe K, Gatanaga H, de Cadiz AE, Tanuma J, Nozaki T, Oka S. Amebiasis in HIV-1-infected Japanese men: clinical features and response to therapy. PLoS Neglected Tropical Diseases 2011;5(9):1-5.
304. WHO Expert Committee on Amoebiasis. Amoebiasis. Report of a WHO Expert Committee. World Health Organization Technical Report Series 1969;421:1-52.
305. World Health Organization. Amoebiasis and its control. A WHO Meeting. Bulletin of the World Health Organization 1985;63(3):417-26.
306. World Health Organization. Diarrhoeal Disease Control Programme. The Management of Bloody Diarrhoea in Young Children [WHO/CDD/94.49]. Geneva: World Health Organization, 1994.
307. World Health Organization. WHO Model Prescribing Information: Drugs Used in Parasitic Diseases. 2nd Edition. Geneva: World Health Organization, 1995.
308. World Health Organization/Pan American Health Organization/UNESCO. Amoebiasis. Weekly Epidemiological Record 1997;72:97-9.
309. World Health Organization. The Treatment of Diarrhoea: A Manual for Physicians and Other Senior Health Workers [WHO/FCH/CAH/05.1]. 4th Edition. Geneva: World Health Organization, 2005.
310. Wilson IW, Weedall GD, Hall N. Host-parasite interactions in Entamoeba histolytica and Entamoeba dispar: what have we learned from their genomes?. Parasite Immunology 2012;34:90-9.
311. Ximénez C, Morán P, Rojas L, Valadez A, Gómez A, Ramiro M, et al. Novelties on amoebiasis: a neglected tropical disease. Journal of Global Infectious Diseases 2011;3(2):166-74.
312. Zhou F, Li M, Li X, Yang Y, Gao C, Jin Q, Gao L. Seroprevalence of Entamoeba histolytica infection among Chinese men who have sex with men. PLoS Neglected Tropical Diseases 2013;7(5):1-7.
313. Gonzales MLM, Dans LF, Martinez EG. Antiamoebic drugs for treating amoebic colitis. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006085]
314. Gonzales MLM, Dans LF, Martinez EG. Antiamoebic drugs for treating amoebic colitis. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006085.pub2]